Benzinga's Top #PreMarket Losers

By: via Benzinga
Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 11.32 percent to $89.15 in pre-market after falling 0.24 percent on Tuesday. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.